Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Precipio (PRPO)
:PRPO
Holding PRPO?
Track your performance easily
Earnings Data
Report Date
May 14, 2025TBA Not Confirmed
Period Ending
2025 (Q1)Consensus EPS Forecast
―Last Year’s EPS
―Same Quarter Last Year
Based on 0 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Nov 19, 2018
|% Change Since: 5.17%
|Next Earnings Date:Aug 17, 2018
Earnings Call Sentiment|Positive
The earnings call reflects a strong positive sentiment with significant growth in case numbers, improved financial performance, and substantial progress towards breakeven, despite challenges in the Products division.Company Guidance
During the Q3 2024 earnings call for Precipio, CEO Ilan Danieli provided detailed guidance on the company's performance and future outlook. The Pathology division exceeded its breakeven point for the second consecutive quarter, achieving $4.5 million in revenue, marking an 18% increase from Q2. The Products division, though not yet at breakeven, showed a promising 13% revenue growth, reaching $680,000. Danieli highlighted a significant reduction in cash burn from approximately $1 million in Q3 2023 to $226,000, reflecting a 75% improvement. He assured stakeholders that the company is on track for breakeven, with no immediate need for capital raises. Looking ahead, Precipio aims to enhance investor education and visibility through consistent performance and participation in investor conferences, ultimately aiming to boost trading volume and share price.Achievement of 10,000 Case Mark
Precipio reached 10,000 cases in 2024 compared to close to 8,000 in 2023, showcasing growth in their impact and reach.
Pathology Division Revenue Growth
Pathology division revenues exceeded breakeven for the second consecutive quarter with a robust 18% increase from Q2, reaching $4.5 million per quarter.
Reduction in Cash Burn
Cash burn reduced by 75% from $1 million in 2023 to $226,000 in 2024, indicating improved financial performance and growth.
Progress Towards Breakeven
The company is well on track to achieve breakeven in 2024, marking a significant operational milestone and avoiding the need for dilutive capital raises.
Products Division Revenue Increase
Products division revenues increased by 13% over Q2, reaching $680,000, with expectations for further growth as new customers are onboarded.
---
PRPO Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
PRPO Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Nov 18, 2024 | $6.19 | $6.08 | -1.78% |
| Aug 19, 2024 | $5.41 | $5.82 | +7.58% |
| May 15, 2024 | $6.49 | $6.24 | -3.85% |
| Nov 20, 2023 | $7.10 | $7.13 | +0.42% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Precipio (PRPO) report earnings?
Precipio (PRPO) is schdueled to report earning on May 14, 2025, TBA Not Confirmed.
What is Precipio (PRPO) earnings time?
Precipio (PRPO) earnings time is at May 14, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is PRPO EPS forecast?
Currently, no data Available
---